Published in Pain and Central Nervous System Week, June 23rd, 2003
The clinical trial program, known as the SAINT (Stroke - Acute Ischemic - NXY Treatment) Trials, will compare the efficacy and safety of a 72-hour intravenous infusion of Cerovive given within 6 hours of the onset of symptoms, versus placebo.
Two multinational, multicenter, double-blind, randomized, placebo-controlled parallel-group studies will be enrolling more than 3000 patients. The SAINT-I trial will involve 200 centers...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week